NRG Oncology Weekly Broadcast for April 29, 2024: conta.cc/3UChQf1

More on the results of NRG Oncology The GOG Foundation Inc. #279: #Phase II Trial of #Cisplatin , #Gemcitabine , and Intensity-Modulated Radiation Therapy for Locally Advanced Vulvar Squamous Cell Carcinoma. Online in Journal of Clinical Oncology

#IMRT #vulvarcancer #ClinicalTrials #gyncsm
Vulvar Cancer Vulvar Cancer

During April (& year-round), cancer prevention is the goal, so we aim to promote awareness for early screening for cancer to ensure early detection. Learn about the different screenings for cancer on National Cancer Institute website: cancer.gov/about-cancer/s…

Cancer prevention research is directed towards improving current treatments & survival rates among people w/cancer & improving their quality of life. Learn more about NRG’s cancer prevention trials currently enrolling participants: @FORTEStudy & SOROCk. nrgoncology.org

Reminder – the April newsletter is now available! Read #headandneckcancerawarenessmonth updates, NCORP updates, and more! Edition available here: conta.cc/49vuBMO

Researchers believe most ovarian cancers begin in the Fallopian tubes. The SOROCk trial is evaluating if removing just the tubes will similarly decrease cancer risk, as well as improve quality of life in BRCA1 patients. Visit nrgoncology.org/SOROCk or scan QR code for more info.

And we’re off to a great line up of engaging educational programming at this summer’s NRG Oncology! Mark your calendars! #Cancer

NRG Oncology Serum Bank Transition. Read more: conta.cc/4d3LhxX

NRG Oncology Weekly Broadcast for April 22, 2024: conta.cc/3UsHKBQ

👉NRG Oncology folks!!!
Planning a fantastic dedicated workshop “Management of Acute and Late Effects of Multimodality Therapy in HNC Patients and Survivors”
At the Sheraton Denver Downtown Hotel approx 12-5pm on Thurs July 25
Then HN meetings on Friday!
👉Plan to arrive by Thurs AM!!

Happy Earth Day! #EarthDay #EarthDay EveryDay

April is Cancer Prevention & Early Detection Month. The @CDC-Cancer has helpful information about screenings for certain cancers posted on their website. ow.ly/YSUj50R6PSZ

Grateful for our department RadOncUH under the leadership of Daniel E Spratt to receive a shoutout at the 2024 University Hospitals State of Research Address by Daniel I. Simon, M.D. highlighting the success of @Lauren_Henke & the The McClelland Lab!
#RadOnc #NAVAH #AdaptiveRT #bcsm #pcsm #KillCancer

NRG-HN014 is one of our trials in development highlights for #HeadandNeckCancer Awareness Month! Learn a bit more about the upcoming study for resectable stage III/IV cutaneous squamous cell carcinoma: ow.ly/rUbI50RcwZp

Congratulations, Dr. Enserro! Danielle Enserro, PhD Appointed the Associate Director of Biostatistics and Statistical Programming - Read more: ow.ly/2bE150RcxtQ

Register today! Study Overview webinars are being offered to review our #breastcancer study, NRG-BR008 - the HERO Trial. Refer to the memo posted on @theCTSU for details on how to register. Lior Braunstein Melissa

The NRG-CC011 Study enrolled the first 2 patients! Learn more about this #clinicaltrial that is examining computerized training to improve concentration, learning new things, and remembering in #breastcancer survivors. nrgoncology.org/CC011 Diane Von Ah

The @FORTEStudy has reached 1,300 participants on March 8th (and currently reached 1,400)! That and other news about FORTE through the past month can be found in their newsletter update here: ow.ly/WOFk50RcxeJ

What is a clinical trial? It is how we find better ways to prevent, diagnose, or treat an illness. The SOROCk trial is an important ovarian cancer prevention study for patients with BRCA1 mutations. Visit nrgoncology.org/SOROCk or scan QR code for more info.

April is Cancer Prevention & Early Detection Month. Screenings are one of the most effective ways to detect cancer in its early and most treatable stages. #GetScreened National Cancer Institute website is a great resource for learning about screenings for cancer: cancer.gov/about-cancer/s…